Topical Repute on Artificial Intelligence-Based Approaches in COVID-19 Supervision

Abstract

The ongoing COVID-19 pandemic has led to a major oppression of worldwide healthcare infrastructure. In current times, artificial intelligence (AI) and network medicine provide groundbreaking implementation of information science in defining diseases, therapeutics, medicines, and in associating targets with the minimum fallacy. In this big data era, artificial intelligence (AI) has immensely reduced the time and investment of novel targeted drug discovery. As there is continual unfolding of the results of the possible drug combinations, exploitation of artificial intelligence is of utmost necessity so as to hone combination therapy plan. Drug repositioning or repurposing is a methodology by means of which subsisting drugs are being manipulated to handle challenging and emerging diseases, including COVID-19. In this chapter, the authors present the regulations on how to use AI to expedite drug repurposing or repositioning, for which AI propositions are not only intimidating but are also inevitable.